Ms. Reid et al., EVIDENCE FOR THE INVOLVEMENT OF PHOSPHOLIPASE A(2) MECHANISMS IN THE DEVELOPMENT OF STIMULANT SENSITIZATION, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 1244-1256
Evidence suggests that phospholipase A(2) (PLA(2)) activation is invol
ved in numerous neuroplastic phenomena, including long-term potentiati
on. Considering the pharmacological similarities between long-term pot
entiation and stimulant sensitization, it seems possible that PLA(2) a
ctivity also might have a role in the induction of stimulant sensitiza
tion. In this study, we have investigated whether PLA(2) inhibition, b
y quinacrine, has any effects on stimulant-induced behavioral sensitiz
ation. Both locomotor and stereotypic behavioral sensitization were do
se-dependently blocked in rats pretreated with quinacrine (8-25 mg/kg
i.p.) 15 min before cocaine (30 mg/kg i.p.), when tested with cocaine
(15 mg/kg i.p) 72 hr later. Similar results also were found with d-amp
hetamine (2 mg/kg i.p,) sensitization using a 10-day treatment regimen
with testing on day 11. The ability of PLA(2) activation, by melittin
, to produce cocaine sensitization also was tested. Local injections o
f melittin (0.1 mu g/0.4 mu l) into the ventral tegmental area sensiti
zed the subsequent stimulation of locomotor activity, stereotypy and n
ucleus accumbens dopamine release by cocaine, when tested 72 hr later.
Local injections of melittin (0.1-1.0 mu g/0.8 mu l) into the nucleus
accumbens had a moderate sensitizing effect on locomotion. Quinacrine
(16 mg/kg) pretreatment 45 min before intraventral tegmental area mel
ittin injection significantly decreased melittin-induced sensitization
of the locomotor and stereotypy response to cocaine. These results in
dicate that PLA(2) activation may play a role in the induction of stim
ulant sensitization. It is proposed that PLA(2) activity in mesolimbic
dopamine neurons, at the level of the cell bodies and perhaps the ner
ve terminals, is involved in the biochemical mechanisms mediating the
development of stimulant sensitization.